Arcturus Therapeutics Holdings Inc (ARCT)

NASDAQ
35.09
+1.20(+3.54%)
After Hours
35.09
0.00(0.00%)
- Real-time Data
  • Volume:
    1,089,152
  • Bid/Ask:
    35.09/35.50
  • Day's Range:
    32.53 - 35.13

ARCT Overview

Prev. Close
33.89
Day's Range
32.53-35.13
Revenue
9.02M
Open
33.5
52 wk Range
24.87-129.12
EPS
-4.86
Volume
1,089,152
Market Cap
923.58M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
547,611
P/E Ratio
-
Beta
2.73
1-Year Change
-14.89%
Shares Outstanding
26,320,274
Next Earnings Date
Aug 09, 2021
What is your sentiment on Arcturus Therapeutics Holdings Inc?
or
Market is currently closed. Voting is open during market hours.

Arcturus Therapeutics Holdings Inc News

Arcturus Therapeutics Holdings Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuySell
SummaryStrong BuyStrong BuyStrong BuyStrong BuySell

Arcturus Therapeutics Holdings Inc Company Profile

Arcturus Therapeutics Holdings Inc Company Profile

Employees
118

Arcturus Therapeutics Holdings Inc. is a clinical-stage messenger ribonucleic acid (mRNA) medicines and vaccines company. The Company’s technologies include LUNAR lipid-mediated delivery, STARR mRNA Technology and mRNA drug substance along with drug product manufacturing. Its pipeline of ribonucleic acid (RNA) therapeutic candidates include programs to treat ornithine transcarbamylase (OTC) deficiency, cystic fibrosis, glycogen storage disease type three, hepatitis B, non-alcoholic steatohepatitis (NASH) and a self-replicating mRNA vaccine for severe acute respiratory syndrome coronavirus two (SARS-CoV-2). Its RNA therapeutics platforms have applications in types of nucleic acid medicines, including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, deoxyribonucleic acid (DNA) and gene editing therapeutics. The Company is focused on liver and respiratory diseases.

Read More
  • A forgotten world...
    0
    • Will this company eventually end up bankruptcy?
      1
  • Earning reporting,  Pre market or after close?
    0
    • Earing reports is disappointed, a fall knive.
      0
  • Let's start the new uptrend
    0
    • It broke the 35 supporting level
      0
      • What will happen after the Q1 earning report?
        0
        • lets FLY baby
          0
          • Guys, any news?
            0
            • hi.nothing. unless the third phase starts soon.
              0
          • letsFly
            0
            • why?
              0
            • Jason Morroisit was joke
              0
          • Next stop, 40
            1
            • Seems I am right here, the next question is will it below 40?
              1
          • This is the ceo: https://scholar.google.com/citations?user=RbIXgvUAAAAJ&hl=en
            0
            • When is rhe next plunge?
              0
              • sold
                5
                • if phase 2 preliminary result is encouraging it should hit $100. if not, it will plunge
                  0
                  • when does phase 2 results come out?
                    0
                • if phase 2 preliminary result is encouraging it should hit $100. if not, it will plunge
                  0
                  • tomorrow 90? have thoughts
                    0
                    • pull back to 57, why? NO IDEA, not sure why it jumped up to 66 good lawd!
                      0
                    • That's a bit too hopeful, but it might reach that by the end of the month. I scaled a bit out of my position of 4k shares. Once it reaches 90-ish, I'll keep a thousand. It was a bit scary to go long on a company with that bad news, but they're actually a decent company. They'll do good things in the future.This is the largest swing trade and most profitable one I've ever done, outside of TSLA of course (not holding forever, just until people move on. I thought they would've moved on after the inclusion into the SP500, but whatever makes me money. Been swinging since 490 for 200 shares.)
                      0
                    • trail sold at 68😒
                      0
                  • Dear who thinks what for tomorrow growth?
                    0
                    • anybody knows what is catalyst?
                      0
                      • BUY CHECK CAP LTD ASAP
                        0
                        • 🤣🤣🤣🎈
                          0
                      • Great start, to climb back to 60 Dollar soon!
                        0
                        • or 0.60 lol
                          3
                        • 60 👍
                          0
                        • what do you think? It will go more than 70's
                          0
                      • what d f is happening here?
                        0
                        • Stay away from this one....the news isn't good.
                          6
                          • al fish those two  approved vaccines -also ******** they were just approved, that's it
                            0
                          • Arkg hasnt pulled out yet, good sign
                            0
                          • Hope you made money on this Fernando while you could.it's only been three months.
                            0
                        • B.Riley Financial analyst Mayank Mamtani maintained a Buy rating on Arcturus Therapeutics (NASDAQ:ARCT) on Tuesday, setting a price target of $138, which is approximately 49.32% above the present share price of $92.42.
                          2
                          • 100% good long position, buy cheap now before 2021!.
                            2
                            • yeah, if it's price is $10. Why do you think that $40+ is a good price?
                              0
                          • Why down in aftermarket??
                            0
                            • Check Cathie Woods Ark Invest statement after hours. She is saying that is an overreacting after press release. Stock should find strong resistance at 51. They will hold position.The press release was wrong interpreted by many. And was a panic sell off. Lets see what will happen
                              1
                            • Do mean support at 51?
                              0
                            • ofcourse support.But she was not true.
                              0
                          • That is brutal...
                            0
                            • This is dragging down ARKG...
                              0
                            • I'm not surprised. But I'm curious why it's dropping. Sell the news, I suppose? I'm not in it at all (other than ARKG), but it was on my watchlist. EDIT and ARKG is where I've invested. I guess this might be a good long tomorrow?
                              0
                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.